Hypertension, the most frequently diagnosed clinical condition world-wide, predisposes individuals to morbidity and mortality, yet its underlying pathological etiologies are poorly understood. So far, a large number of quantitative trait loci (QTLs) have been identified in both humans and animal models, but how they function together in determining overall blood pressure (BP) in physiological settings is unknown. Here, we systematically and comprehensively performed pair-wise comparisons of individual QTLs to create a global picture of their functionality in an inbred rat model. Rather than each of numerous QTLs contributing to infinitesimal BP increments, a modularized pattern arises: two epistatic 'blocks' constitute basic functional 'units' for nearly all QTLs, designated as epistatic module 1 (EM1) and EM2. This modularization dictates the magnitude and scope of BP effects. Any EM1 member can contribute to BP additively to that of EM2, but not to those of the same module. Members of each EM display epistatic hierarchy, which seems to reflect a related functional pathway. Rat homologues of 11 human BP QTLs belong to either EM1 or EM2. Unique insights emerge into the novel genetic mechanism and hierarchy determining BP in the Dahl salt-sensitive SS/Jr (DSS) rat model that implicate a portion of human QTLs. Elucidating the pathways underlying EM1 and EM2 may reveal the genetic regulation of BP.
INTRODUCTION
Essential hypertension, the most prominent of human disorders, leads to stroke and fatal cardiovascular diseases (1, 2) . Up to now, hypertension is under control in only 34% of patients, and even for them, available treatments are empirical at best as they are not directed at causes of the disease, but rather at symptoms that require life-long medication (3) . The greatest challenge in finding primary triggers, not secondary responses, to essential hypertension is to identify quantitative trait loci (QTLs) that underlie the physiological etiologies of blood pressure (BP) determination (2). Genome-wide association studies (GWAS) in humans have localized QTLs for systolic (SBP) and diastolic BP (DBP) (2, 4) , mean arterial pressure (MAP) and pulse pressure (5) .
Each QTL is assumed to exert a miniscule phenotypic effect, and multiple QTLs work together to incrementally augment BP. Evidently, 28 human QTLs (2) account for ,1% of total BP changes. By inference, thousands of such QTLs would have to exist to explain the majority of BP variations in general human populations. Although fractionating polygenic risk factors is often adopted in epidemiological studies, the biological impact of such practice in a functional context remains enigmatic.
Coincidentally, experimental models of hypertension have yielded numerous QTLs (6, 7) . Are they required as quantitative increments cumulatively achieving a BP threshold? In this context, how do Dahl salt-sensitive SS/Jr (DSS) rats, that possess BP-lowering alleles at several QTLs, stay hypertensive (8, 9) ? Is it because they have more BP-elevating than BP-diminishing QTL alleles that mathematically counterbalance one another?
These issues have to be addressed experimentally, i.e. via the investigation of each QTL individually and in combination with another, while retaining the rest of the genome homogeneously constant. This approach is not feasible in clinical studies, but the insights gained are valuable for understanding the genetic † These authors contributed equally to the current work. * To whom correspondence should be addressed at: CRCHUM-Technopôle Angus, 2901 Rachel St East-Room 312, Montréal, Québec, Canada H1W 4A4. Tel: +1 5148908000; Fax: +1 5144127655; Email: alan.deng@umontreal.ca hierarchy and organization of essential hypertension. The current work aims to elucidate the organization that assembles and configures the genetic architecture that determines BP in DSS rats.
RESULTS

Study design in grouping QTLs
In isolation, the effect magnitude from a single QTL accounts for at least 20% of the BP difference between two contrasting parental strains, and no combination with another QTL is necessary to achieve it (Supplementary Material, Fig. S1 ). Epistasis refers to the effect of one gene masking that of another when acting together (6) . Epistatic interactions predict that the BP effects of 2 QTLs cannot exceed those of a single QTL alone (10) . Based on this phenomenon, Deng proposed (6) a modularized scheme in that multiple BP QTLs may be assembled on the basis of their epistatic interactions or lack thereof.
To accomplish this task, one QTL can be used as a reference/ entry point to which several QTLs can be modularized. A new component in the same epistatic module (EM) can be discovered by making a 'double' congenic strain, combining a QTL known to be a component of one starting module with another QTL whose modular involvement is not evident. If such a 'double' congenic strain has the same BP as each of the two 'single' congenic strains that constitute it, the two QTLs behave epistatically to each other and, consequently, they can be grouped into the same module. If not, they belong to a different module. By repeating this process with all the known QTLs, more components of the same EM can be added into the existing modular network, and an independent module can be established.
Epistatic hierarchy among QTLs in the same module can be determined whether two QTLs have discernible BP effects. For example, a BP-decreasing QTL stands clearly higher in epistatic hierarchy than a BP-increasing QTL on Chromosome (Chr) 3, because the combined effects of the two QTLs are the same as those of the BP-decreasing QTL alone (11) . Based on this rationale, the following experiments were performed.
As a starting point, combination of two congenic strains, C10S.L30 (containing C10QTL1) and C10S.L16 (containing C10QTL2) (Supplementary Material, Fig. S1F ), proved that they act additively (Table 1 and Fig. 1A ). C10 refers to Chr 10. S.L30 indicates that the congenic strain, #30, was made in the genetic background of DSS rats (see section 'Materials and Methods' for details). QTL2 refers to QTL #2 on Chr 10.
C10QTL1 and C10QTL2 served as two initiating and separate reference/entry points onto which all QTLs (Supplementary Material, Table S1 ) could be modularized for their mutual epistatic relationships (6) . A new member of the C10QTL1 module, i.e. EM1, can be found if that QTL acts epistatically to it, such as C10QTL5 (12) . The same principle applies to the module composed of C10QTL2, i.e. EM2. A new EM, in addition to EM1 and EM2, can be discovered if a given QTL acts additively with both C10QTL1 and C10QTL2.
Modularization of BP QTLs
An analysis was first performed of C10QTL4 and C10QTL2 by combining two separate congenic strains, C10S.L28 and C10S.L16 (Supplementary Material, Fig. S1F ), into one single congenic strain, C10S.L28/C10S.L16. The combined effect of C10QTL4 + C10QTL2 did not exceed that of C10QTL4 or C10QTL2 alone (Table 1 and Fig. 1B ), i.e. an epistatic interaction exists between them (P , 0.002). Thus, C10QTL4 and C10QTL2 belong to EM2 (Table 2) .
Next, the interaction between C10QTL1 and C16QTL was evaluated by combining two congenic strains, C10S.L30 and C16S.L7 (Supplementary Material, Fig. S1F and G) into a single congenic strain, C10S.L30/C16S.L7. Simultaneously, the C10S.L16/C16S.L7 combination was produced to assess the interaction between C10QTL2 and C16QTL. C16QTL behaves epistatically with C10QTL1 (P ¼ 0.049), but additively with C10QTL2 (P ¼ 0.31) ( Table 1 and Fig. 1C and D) . Thus, C16QTL and C10QTL1 belong to EM1. Modeled on classifying C16QTL, other QTLs were analyzed in 'double' congenic combinations. In all, 27 'double' congenic combinations were created and independently examined ( Table 1 ). All QTLs (Supplementary Material, Fig. S1 ) participated in either EM1 or EM2 except for C2QTL1 (Table 2 ). C2QTL1 acted additively with both C10QTL1 and C10QTL2, and, consequently, belongs to a separate EM: EM3.
EM1, EM2 and EM3 have 16, 8 and 1 members, respectively ( Table 2 ). Three QTLs belonged to either EM1 or EM2, but their precise classification was not established. Genetic hierarchy exists among the QTLs in each module. In EM2, the BP-decreasing C10QTL2 stands higher in hierarchy than the BP-increasing C8QTL2, because the effect of C10QTL2 masks that of C8QTL2, not vice versa (Table 1 and Fig. 1F ).
Next, we addressed the issue of whether or not modularized groupings of BP QTLs had biological meanings or were just statistical rituals devoid of them. We reasoned that, if EM1 and EM2 were fundamental function blocks, BP should stay constant, regardless of how many QTLs are present from each module.
Biological significance of QTL modularization
To prove that EM1 and EM2 constitute two essential functional cores in BP regulation, we generated multiple QTL combinations, each of them containing at least one member from EM1 and EM2, all carrying BP-lowering QTL alleles (Supplementary Material, Table S1 ). Three to eight BP QTL combinations were similar (P . 0.15) to those of two QTLs (C10QT1 + C10QTL2) (Fig. 2) , as if EM1 + EM2 exerted a 'ground floor' effect. This outcome was not due to bottom limit, because the BP of Lewis rats (95 mmHg) seemed still lower (P , 0.001) than that of EM1 + EM2 combined (110 -125 mmHg). Consequently, more QTLs beyond the two core members, each from EM1 and EM2, became redundant rather than cumulative in their combined impact on BP.
Next, we examined correspondence between the BP QTLs found in our animal model and those identified in humans.
Implications of modularization for human QTLs
Eleven out of 42 (26%) human genes or QTL intervals (underlined in Supplementary Material, Table S2 ) (2, 4, 5) were included in eight congenic strains demonstrating BP effects. Their rat homologues belonged to either EM1 or EM2 affecting BP. MOV10, CAPZA1 and FIGN/GRB14 were contained in large Fig. S1A ) that interact epistatically with C10QTL1 + C10QTL2 (Table 1) , i.e. they belong to either EM1 or EM2 (Table 2 ). C3S.L7 (14) carries the segment harboring Jag1/ Gnas/EDN3, corresponding to C3QTL3 (EM1) ( Table 2 and Supplementary Material, Fig. S1B ). The coding regions and exon-intron junctions for Adm (15) Although a non-synonymous HFE SNP is associated with human BP (2), and Hfe is situated in the C17QTL2-lodging interval (Supplementary Material, Fig. S1H ), no structural and splicing Hfe mutations were detected (Supplementary Material, Table S3C ). Barring variants impacting on their gene expressions, Adm, Edn3 and Hfe themselves are not supported as BP QTLs. Nevertheless, C17QTL2 marked by Hfe exists and belongs to EM2 (Table 2) .
Eleven out of 42 human QTLs, such as GUCY1A3-GUCY1B3, SLC39A8, and NPR3-C5orf23, were excluded as BP QTLs contrasting DSS rats with a specific normotensive strain (Table 2 and Supplementary Material, Fig. S1E ). They may still influence BP in other strain comparisons, because different normotensive, and probable hypertensive, strains may have distinctive genetic MAP, mean arterial pressure; DSS, Dahl salt-sensitive rats. QTL-QTL interactions were analyzed by 2 × 2 ANOVA as presented in Figure 1 and analyzed as described in the Figure 1 legend. No multiple comparisons were made between studies concerning epistatic interactions or a lack of it. Congenic strains defining QTLs are reported in Supplementary Material, Figure S1 .
determinants (18) . Thus, the specific gene for these human QTLs awaits functional identifications.
DISCUSSION
Significant revelations from this study are: (i) 28 QTLs that can provoke hypertension regulate BP via three functional modules, namely, EM1, EM2 and EM3. Modularity in QTL actions gives rise to a novel genetic concept. This unique mechanism may help shed light on the functionality of certain human BP QTLs.
(ii) EM1 and EM2 are fundamental modules that provide novel insights into the genetic mechanisms and hierarchy globally governing BP homeostasis.
Epistatic modularization, not quantitative accumulation, is the modus operandi in biological BP determination by QTLs
The prevailing view is that a complex and quantitative trait, such as BP, must be realized by arithmetic accumulation of numerous Figure 1 . Analysis of interactions among representative QTLs. The left three columns in each panel represent differences in mean arterial pressure (MAP) between a congenic and DSS strains, i.e. BP lowered by a congenic strain. The last column to the right indicates a 'predicted' value of MAP lowered by combining two different QTLs. The BP effect of C10QTL1 is represented by congenic strain C10S.L30; the BP effect of C10QTL2 is represented by congenic strain C10S.L16; the combined BP effect of (C10QTL1 and C10QTL2) is represent by a 'double' congenic strain C10S.L30 + C10S.L16. P indicates the results on the interaction as performed by 2 × 2 ANOVA. The actually 'observed' BP effect of the 'double' congenic strain combining C10QTL1 + C10QTl2 is not different (P interaction ,0.067) from a 'predicted' sum of BP effects of C10QTL1 + C10QTL2, indicating additivity. In contrast, the actually 'observed' BP effect of another 'double' congenic strain combining C10QTL2 + C10QTL4 is different (P interaction ,0.002) from a 'predicted' sum of BP effects of C10QTL2 + C10QTL4, indicating epistasis. (A) Addivity between C10QTL1 and C10QTL4; (B) epistasis between C10QTL2 and C10QTL4; (C) addivity between C10QTL2 and C16QTL; (D) epistasis between C10QTL1 and C16QTL; (E) addivity between C8QTL2 and C10QTL1; (F) epistasis between C8QTL2 and C10QTL2.
QTLs, each of which has only a miniscule influence on overall phenotype. Counter-intuitively, the effects of DSS QTLs individually and in assembly do not produce a spectrum of continuous BP variations, but rather impact BP as 'units' in relatively clear-cut 'leaps' (Fig. 2) . This genetic insight suggests that the aggregating outcome of multiple QTLs in DSS rats is achieved via a modularized mechanism, not progressive increments. All QTLs in the same EM may be interpreted to be components up-or down-stream in a common pathway. Accordingly, EM1 and EM2 seem to be multi-component pathways. The modularized modality of QTLs in controlling BP in the DSS inbred model has added a new dimension to, but does not nullify or replace, the established norm governing those in outbred populations at large. BP appears as a continuum in a distribution curve in general human populations (2) and outbred animals. The gene actions determining this continuum should now include the modularized mechanism in addition to the small-effect-but-cumulative paradigm (2) .
Although the modularity of BP QTLs does exist in an inbred model, it is not evident whether or not, and to what extent, it can be generalized to an outbred population, such as in humans. An outbred population consists of myriad individuals, and each of them, or monozygotic twins (or multiple births), can be viewed as an inbred strain. Conceivably, QTLs may be modularized in their influence on BP in some individuals, but not in others. It is possible that certain QTLs may be modularized across heterogeneous individuals. The only way to establish modularity between two QTLs is to isolate a QTL and then combine both of them. This approach is not achievable in outbred populations, but individual QTLs can be isolated in inbred rodent models and tested, as in the current study.
In this context, it is necessary to distinguish the actual biological impact of a QTL from the statistically estimated magnitude of phenotypic effect and the statistically fractionated contribution of each QTL to the whole phenotype. For example, after typical genetic analysis in a F2(DSS × Lewis) population (19) , the magnitude of BP effect for each QTL was calculated and the contribution to global BP calculated statistically as a percentage, accounting for total variance. While these estimates are widely accepted as the standard genetic interpretation of a QTL action (20) , the true biological effects of QTLs individually and in combination only become clear in isolation and in pair-wise combinations. It turns out that all QTLs contrasting DSS and Lewis rats are modularized in their effects on BP ( Table 2 ). Considering that individuals in an F2 population are genetically heterogeneous, they approximately resemble an outbred population. Thus, the statistical treatment of QTLs in an outbred or F2 population follows the principles of population genetics, whereas the modularity of QTLs is governed by their biological impact on BP. They represent two different aspects of QTL characterization, namely, statistical versus biological, depending on the context of analysis and the rigor of functional validation.
Discovering QTL modularity is important in that it paves the way for identifying and understanding a common pathway to BP homeostasis and the hierarchical relationship among pathway components.
Once again, the limited application of the modularized mechanism is obvious, as it appears in inbred strains. This mechanism is yet to be tested in outbred populations. Whether or not QTLs would function cumulatively or otherwise in a physiological setting in outbred human populations awaits further functional proof beyond simple statistics. Nevertheless, the modularity exists as shown in our current work, and is a possibility that warrants attention in the future research of human polygenic hypertension.
Pathway of EMs
Candidate genes have been identified for several QTLs in EM1. They are Loc100363423 for C10QTL3, Proline-rich 11 (Prr11) for C10QTL5, Alpha kinase 2 (Alpk2) for C18QTL3, and five candidates for C10QTL1 (Table 2 and Supplementary Material, Fig. S1 ). Since all these genes are not known to regulate BP biologically and even their cellular functions are not identified, the physiological mechanisms by which they influence BP might fall in the same pathway, because they belong to the same module. This framework may pave the way for identifying one QTL based on a known mechanism of another QTL in the same EM. For example, assuming that Alpk2 may encode a kinase that might be involved in BP control, PRR11 could somehow participate in the ALPK2 pathway.
One candidate gene was found for C10QTL2 in EM2 to be ATP-binding cassette, subfamily A (ABC1), member 8a (Abca8a). ABCA8A belongs to a family of transporters that are implicated in the high-density lipoprotein metabolism, atherogenesis and coronary heart disease via control of cholesterol efflux (21) . The mechanism of its involvement in BP homeostasis is not known, but based on Abca8a being in EM2, the mode of its action may be independent of those of Alpk2 and Prr11, which belong to EM1. QTLs in parentheses belong to either EM1 or EM2. All QTL-QTL interactions were assessed in the current work except for those closely linked on the same chromosome, such as C2QTL2, C2QTL4M, C2QTL5 and C2QTL6, being in the same epistatic module, EM1 (29), C3QTL1 and C3QTL2 in the same module (11), C10QTL1, C10QTL3 and C10QTL5 in the same module (10, 12) , and C18QTL1, C18QTL2, C18QTL3 and C18QTL4 in the same module (27, 30) . Abca8a and Ppr11 are identified from (31), and Alpk2 from (30).
Nevertheless, these QTLs in EM1 and EM2 are novel and may influence BP either directly or indirectly via regulation of other genes or their products known to affect BP.
In contrast, genes encoding well-known molecules are either excluded or unsupported as etiologically BP-impacting agents, such as Ace, Nos2, Adm, Edn3, Npr1, Npr3, Gucy1a3, Gucy1b3, Atp1a1, Adrb2 and Nedd4l (Table 2 and Supplementary Material, Fig. S1 ). How can they be important in BP regulation? One possibility is that they may not be primary triggers, but secondary responders to triggers such as Abca8a and Prr11 in BP homeostasis.
Given the power of resolution in modern GWAS of BP QTLs, only 11 human QTLs corresponding to those found in the Dahl Fig. S1G and H) . A 2-QTL combination was achieved by combining 2 congenic strains carrying them, then 3, 4, and so on. Two (or multiple) closely linked QTLs are combined into a congenic strain containing both of them (or multiples). Two QTLs are C10QTL1 (epitomizing EM1) + C10QTL2 (exemplifying EM2); three QTLs are C10QTL4 (EM2) + C18QTL3 (EM1) + C2QTL6 (EM1); four QTLs (Table 2) . ANOVA + Dunnett values for all BP components are P , 0.03 (most conservative) for DSS versus congenic strains trapping QTLs; P , 0.01 for congenic strains harboring C16QTL or C17QTL1 versus congenic strains containing two to eight QTLs and Lewis. model were detected. The majority of rat QTLs were 'missed', especially those on Chr 2, 10 and 18, in human studies (Supplementary Material, Fig. S1 ).
A few factors may explain this discrepancy. First, certain QTLs found in rats may be rodent-specific and they may not function as triggers to initiate hypertension in humans. Second, since a high-salt diet was included in the BP protocol, certain QTLs found under this condition may mostly apply to salt-accelerated hypertension. Third, in human studies, both women and men were assumed to be recruited and the data on them were pooled, whereas in our current animal model, only males were investigated. There is evidence that some rat QTLs affect BP only in males, not in females (22) . Thus, certain rat QTLs may be sex-specific. Finally, some rat QTLs were detected only when the genetic background was homogeneous, not when it was heterogeneous. For example, a QTL on Chr 7 was detected only in a congenic strain (18) , but was missed in a F 2 (DSS × Lewis) population (19) . Human populations are heterogeneous, whereas our congenic strains are homogeneous.
In summary, multiple QTLs function via specific modules in the inbred DSS model. In designing anti-hypertensive drugs, simultaneously targeting mediators in two separate modules seems more effective in lowering BP of a hypertensive individual than targeting those in the same module. Functional hierarchy exists among QTLs in the same EM, which is demonstrated by the interplay between BP-increasing and BP-decreasing QTL alleles. Twenty-six per cent of human QTLs have rat homologues that belong to EM1 and EM2 combined, implying that certain human QTLs might function via a modularized mechanism. The QTLs identified in animal models (Supplementary Material, Table S1 ) may facilitate the discovery of further genetic architecture in humans that is hidden from the most powerful GWAS, but is pertinent to essential hypertension, since 116 human QTLs are estimated to exist (2) and only 28 have been found.
MATERIALS AND METHODS
Animals
Although inbred DSS rats are known as a model of saltsensitivity (23), the QTLs governing their BP can act either on low-or high-salt diets (24) . Thus, the genetic determination of hypertension in DSS rats can serve as a general model of essential hypertension. Protocols for handling and maintaining animals were approved by our institutional animal ethics committee (CIPA).
Construction of new congenic strains or substrains
DSS and Lewis rats were parents in the production of congenic strains. Breeding and screening procedures were accelerated similarly to those reported previously (8) . New strains were validated by polymorphic microsatellite markers with an overall marker density of 10-20 cM/marker across the genome. The genotypes of markers are indicated in Supplementary Material, Fig. S1 for the region where crossovers were sought to derive congenic substrains. In the current work, four new congenic strains were produced (Supplementary Material, Fig. S1A and C) and designated as C1S.L2, C1S.L3, C1S.L4 and C5S.L. C1 refers to Chr 1; S.L denotes congenic substitution of a chromosomal segment from hypertensive DSS rats by their homologue from Lewis rats in the DSS genetic background. A number following S.L indicate number of congenic strains.
One new subline came from C16S.L5 (14) , designated as C16S.L7 (Supplementary Material, Fig. S1G ). Three new sublines were derived from C17S.L2 (25) , designated as C17S.L9, C17S.L11 and C17S.L12, respectively (Supplementary Material, Fig. S1H ).
Systematic assessment of QTL -QTL interactions by congenic combinations
A congenic strain relies on specific replacement of a Chr segment from the recipient strain by its homolog from a donor, while keeping the remaining genome as that of the recipient (26) . In a sense, the congenic strategy is similar to that of 'knock in'. If BP changes in a congenic strain, a QTL should reside within the Chr segment replaced.
Supplementary Material, Figure S1 depicts congenic strains entrapping the QTLs under study. Only congenic strains produced in the DSS genetic background were utilized, because those made in the Lewis background did not exhibit any BP effect (18, 27) and thus cannot be informative on QTL -QTL interactions.
Each interaction was tested independently in that each time only three strains in a comparison were measured for BP along with DSS rats. For example, when analyzing the interaction between C10QTL1 and C10QTL2 (Table 1 and Supplementary Material, Fig. S1A ), only three congenic strains plus DSS were analyzed simultaneously, i.e. DSS, C10S.L30, C10S.L16 and C10S.L30/C10S.L16. To analyze the interaction between C10QTL2 and C10QTL4, only DSS, C10S.L16 (Table 1 and Supplementary Material, Fig. S2B ), C10S.L28 and C10S.L16/ C10S.L28 were studied, and so forth for the remaining comparisons listed in Table 1 .
Animal protocols and BP measurements
Breeding protocols and dietary treatments were the same as reported previously (8) . Male rats were weaned at 21 days of age, maintained on a low-salt diet (0.2% NaCl), then fed a highsalt diet (2% NaCl), starting from 35 days of age until the end of the experiment. Telemetry probes were implanted when the rats were 8 weeks old (i.e. after 3 weeks on the 2% NaCl diet). BPs for all strains were measured continuously for 2 weeks, starting from the 10th day of post-operative recuperation.
Statistical analysis
Repeated measures' analysis of variance (ANOVA) followed by Dunnett's test (taking multiple comparisons and sample sizes into account) compared DBP, SBP and MAP between groups, as reported previously (10, 28) . 2 × 2 ANOVA assessed QTL -QTL interactions (or lack thereof) by evaluating whether the observed effect of a 'double' or 'multiple' congenic strain combining separate QTLs was significantly different from a predicted sum of effects from each individual QTL (10, 28) .
